John A. Hey

Also affiliated with Framingham State University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics”.

APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics

Alzheimer s & Dementia Translational Research & Clinical Interventions(2024)10.1002/trc2.12498

N/A

0.470DataRank · unranked

22 citations

Anton P. Porsteinsson, Marwan Sabbagh, David Watson, Aidan Power, Earvin Liang +8 more

Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00663-w

N/A

0DataRank · unranked

357 citations

Susan Abushakra, John A. Hey, Anton P. Porsteinsson, Marwan N. Sabbagh, Martin Tolar